Correlation Between Quidel and Neuropace

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quidel and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quidel and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quidel and Neuropace, you can compare the effects of market volatilities on Quidel and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quidel with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quidel and Neuropace.

Diversification Opportunities for Quidel and Neuropace

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Quidel and Neuropace is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Quidel and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Quidel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quidel are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Quidel i.e., Quidel and Neuropace go up and down completely randomly.

Pair Corralation between Quidel and Neuropace

Given the investment horizon of 90 days Quidel is expected to generate 2.41 times less return on investment than Neuropace. But when comparing it to its historical volatility, Quidel is 1.25 times less risky than Neuropace. It trades about 0.16 of its potential returns per unit of risk. Neuropace is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest  895.00  in Neuropace on September 17, 2024 and sell it today you would earn a total of  270.00  from holding Neuropace or generate 30.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Quidel  vs.  Neuropace

 Performance 
       Timeline  
Quidel 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Quidel has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical and fundamental indicators, Quidel is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.
Neuropace 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Quidel and Neuropace Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quidel and Neuropace

The main advantage of trading using opposite Quidel and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quidel position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.
The idea behind Quidel and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes